Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Kazuto Nishio"'
Autor:
Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen‐Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nishio
Publikováno v:
Molecular Oncology, Vol 18, Iss 2, Pp 305-316 (2024)
The phase III IMPACT study (UMIN000044738) compared adjuvant gefitinib with cisplatin plus vinorelbine (cis/vin) in completely resected epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC). Although the primary endpo
Externí odkaz:
https://doaj.org/article/5ef9670861fa45fda1c2e13f031a8170
Autor:
Toshiharu Sakurai, Marco A De Velasco, Kazuko Sakai, Tomoyuki Nagai, Hiroki Nishiyama, Kentaro Hashimoto, Hirotsugu Uemura, Hisato Kawakami, Kazuhiko Nakagawa, Hiroyuki Ogata, Kazuto Nishio, Masatoshi Kudo
Publikováno v:
Molecular Oncology, Vol 16, Iss 7, Pp 1493-1507 (2022)
Immune checkpoint inhibitors (ICIs) are widely used to treat various malignancies. Although the gut microbiome is known to influence the efficacy of ICIs on epithelial tumors, the functional interactions between gut taxa and colonic mucosa remain poo
Externí odkaz:
https://doaj.org/article/d953bfb730bd47ca942694545bf5a7ad
Autor:
Esuteru Hirokawa, Satomi Watanabe, Kazuko Sakai, Masayuki Takeda, Chihiro Sato, Takayuki Takahama, Kazuto Nishio, Kazuhiko Nakagawa
Publikováno v:
Thoracic Cancer, Vol 12, Iss 16, Pp 2283-2287 (2021)
Abstract Epidermal growth factor receptor (EGFR) kinase domain duplication (KDD) has been identified as an oncogenic driver in 0.05% to 0.14% of non–small cell lung cancer (NSCLC) patients. However, little is known of the efficacy of EGFR tyrosine
Externí odkaz:
https://doaj.org/article/b44312130d5d4ff78950aefbf9a4ec26
Autor:
Kazuko Sakai, Takayuki Takahama, Mototsugu Shimokawa, Koichi Azuma, Masayuki Takeda, Terufumi Kato, Haruko Daga, Isamu Okamoto, Hiroaki Akamatsu, Shunsuke Teraoka, Akira Ono, Tatsuo Ohira, Toshihide Yokoyama, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Kazuto Nishio
Publikováno v:
Molecular Oncology, Vol 15, Iss 1, Pp 126-137 (2021)
The WJOG8815L phase II clinical study involves patients with non‐small cell lung cancer (NSCLC) that harbored the EGFR T790M mutation, which confers resistance to EGFR tyrosine kinase inhibitors (TKIs). The purpose of this study was to assess the p
Externí odkaz:
https://doaj.org/article/fefce0363b3041d98787f1a3a7d1e18b
Autor:
Toshiaki Takahashi, Makoto Nishio, Kazumi Nishino, Yasumasa Yoshiki, Naoko Shiraiwa, Birol Emir, Laura Iadeluca, Yasushi Yatabe, Kazuto Nishio
Publikováno v:
Cancer Science.
Autor:
Masanobu Tsubaki, Tomoya Takeda, Yuuichi Koumoto, Takehiro Usami, Takuya Matsuda, Shiori Seki, Kazuko Sakai, Kazuto Nishio, Shozo Nishida
Publikováno v:
Cell Proliferation.
Autor:
Hidetoshi Hayashi, Tadashi Aoki, Kazuko Sakai, Toyofumi F. Chen-Yoshikawa, Makoto Nishio, Hirotsugu Kenmotsu, Kenji Sugio, Yuki Sato, Tsuyoshi Ueno, Sho Saeki, Nobuyuki Yamamoto, Kiyotaka Yoh, Yukio Hosomi, Norihito Okumura, Kazuto Nishio, Tatsuo Ohira, Tomohiro Haruki, Hiroaki Akamatsu, Takashi Seto, Toshiaki Takahashi, Akimasa Sekine, Hiromasa Yamamoto, Haruko Daga, Yuichi Takiguchi, Hidetoshi Inokawa, Masahiro Tsuboi, Koji Yamazaki
Publikováno v:
Cancer Science
The mutation status of tumor tissue DNA (n = 389) of resected stage II‐III non‐squamous non–small‐cell lung cancer (Ns‐NSCLC) was analyzed using targeted deep sequencing as an exploratory biomarker study (JIPANG‐TR) for the JIPANG study,
Autor:
Takayuki Yoshino, Kazuko Sakai, Eiichi Morii, Takashi Kubo, Satoshi Fujii, Yae Kanai, Atsushi Ochiai, Hitoshi Ichikawa, Kazuto Nishio, Wataru Okamoto, Kanako C. Hatanaka, Yoshinao Oda, Yutaka Hatanaka, Takeshi Kuwata
Publikováno v:
Pathology International. 71:725-740
Clinical cancer genomic testing based on next-generation sequencing can help select genotype-matched therapy and provide diagnostic and prognostic information. Pathological tissue from malignant tumors obtained during routine practice are frequently
Autor:
Toshiharu Sakurai, Hisato Kawakami, Kazuhiko Nakagawa, Hirotsugu Uemura, Kazuko Sakai, Hiroyuki Ogata, Marco A. De Velasco, Kentaro Hashimoto, Hiroki Nishiyama, Masatoshi Kudo, Tomoyuki Nagai, Kazuto Nishio
Publikováno v:
Molecular Oncology. 16:1493-1507
Immune checkpoint inhibitors (ICIs) are widely used to treat various malignancies. Although the gut microbiome is known to influence the efficacy of ICIs on epithelial tumors, the functional interactions between gut taxa and colonic mucosa remain poo
Autor:
Kuniko Sunami, Tetsu Hayashida, Kazuto Nishio, Shinji Kohsaka, Ichiro Kinoshita, Hiroyuki Uetake, Kenji Tamura, Koshi Mimori, Hideaki Takahashi, Shinichi Toyooka, Noboru Yamamoto, Hideaki Bando, Masayuki Takeda, Keigo Komine, Katsuya Tsuchihara, Yoichi Naito, Yasushi Yatabe
Publikováno v:
Cancer Science
Comprehensive genomic profiling (CGP) is being increasingly used for the routine clinical management of solid cancers. In July 2018, the use of tumor tissue‐based CGP assays became available for all solid cancers under the universal health insuranc